These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6360431)

  • 21. The effect of d-fenfluramine on anterior pituitary hormone release in the rat: in vivo and in vitro studies.
    Serri O; Rasio E
    Can J Physiol Pharmacol; 1987 Dec; 65(12):2449-53. PubMed ID: 3449200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in serum titres of prolactin, somatotropin and thyrotropin induced by fenfluramine in humans.
    Murialdo G; Masturzo P; Reforzo F; Traldi S
    Boll Soc Ital Biol Sper; 1979 Oct; 55(20):2135-41. PubMed ID: 548046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
    Young AH; Rue J; Odontiadis J; Cowen PJ
    Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V; Dinan TG
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans.
    Monteleone P; Bortolotti F; Orazzo C; Serino I; Maj M
    Psychoneuroendocrinology; 1997 Feb; 22(2):79-87. PubMed ID: 9149330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evidence of an interaction between serotonergic and dopaminergic neurons in the control of prolactin secretion in male rats.
    Quattrone A; Schettini G; Di Renzo GF; Preziosi P
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):42-9. PubMed ID: 485703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.
    Thakore JH; O'Keane V; Dinan TG
    Am J Psychiatry; 1996 Nov; 153(11):1460-3. PubMed ID: 8890681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrine and amine responses to D,L-fenfluramine in normal subjects.
    Mitchell PB; Smythe GA
    Psychiatry Res; 1991 Nov; 39(2):141-53. PubMed ID: 1686811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blunted growth hormone (GH) responsiveness to GH-releasing hormone in obese patients: influence of prolonged administration of the serotoninergic drug fenfluramine.
    Argenio GF; Bernini GP; Sgró M; Vivaldi MS; Del Corso C; Santoni R; Franchi F
    Metabolism; 1991 Jul; 40(7):724-7. PubMed ID: 1870427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V; McLoughlin D; Dinan TG
    J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic stimulation of adrenocorticotropin secretion in man.
    Lewis DA; Sherman BM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):458-62. PubMed ID: 6319452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.
    Willoughby JO; Menadue M; Jervois P
    Brain Res; 1982 Oct; 249(2):291-9. PubMed ID: 6291713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.
    Siever LJ; Murphy DL; Slater S; de la Vega E; Lipper S
    Life Sci; 1984 Mar; 34(11):1029-39. PubMed ID: 6700367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin regulation of aldosterone secretion.
    Maestri E; Camellini L; Rossi G; Rossi GP; Dotti C; Marchesi M; Gnudi A
    Horm Metab Res; 1988 Jul; 20(7):457-9. PubMed ID: 2844641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder.
    Coiro V; Volpi R; Marchesi C; De Ferri A; Davoli C; Caffarra P; Rossi G; Caffarri G; Davolio M; Chiodera P
    Psychoneuroendocrinology; 1993; 18(8):551-6. PubMed ID: 8127946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
    Goodwin GM; Murray CL; Bancroft J
    J Affect Disord; 1994 Feb; 30(2):117-22. PubMed ID: 8201126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects.
    Gorard DA; Taylor TM; Medbak SH; Perry LA; Libby GW; Farthing MJ
    Int Clin Psychopharmacol; 1993; 8(2):123-8. PubMed ID: 8393895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of cortisol on spontaneous and 5HT stimulated prolactin release in man.
    Dinan TG; Scott LV
    J Basic Clin Physiol Pharmacol; 1996; 7(1):45-56. PubMed ID: 8983335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.